Trials Sponsors Conditions Drugs Pricing

Conditions

Heart Failure

Keywords

cardio-renal syndromeright heart dysfunctioncentral venous pressureeGFRlow-flow theory

Outcome Measures

Primary Outcomes (1)

renal impairment (defined as a Glomerular Filtration Rate less than 60 mL/min per 1.73 m2)
Estimated Glomerular Filtration Rate has been assessed with the Modification of Diet in Renal Disease formula
through study completion, an average of 1 year

Interventions

CVP measurementOther

CVP measurements had been performed with an electronic pressure transducer in spontaneously breathing non-ventilated patients. Central vein access was established trough the subclavian or internal jugular veins. Mean CVP was recorded for each patient, measured in mmHg.

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 100 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

patients who underwent in-patient treatment at medical centers

You may qualify if:

HF (NYHA class I - IV, with preserved and reduced EF) and reduced GFR (Cardio-Renal Syndromes 1 and 2)

You may not qualify if:

Sponsors & Collaborators

Tbilisi State University
Otherlead

MeSH Terms

Conditions

Heart FailureCardio-Renal Syndrome

Interventions

Central Venous Pressure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Study Officials

George Lobzhanidze, MD
Tbilisi State University
PRINCIPAL INVESTIGATOR

Enrollment

11 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: OTHER
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: MD

Study Record Dates

First Submitted

May 16, 2016

First Posted

June 7, 2016

Study Start

September 2015

Actual (reported)

The Role of CVP and EF in Patients With Cardio-renal Syndromes

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

First Submitted

First Posted

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

First Submitted

First Posted

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record